Colgate-Palmolive (NYSE:CL) Shares Purchased by Boston Common Asset Management LLC

Boston Common Asset Management LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 53.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 268,448 shares of the company’s stock after purchasing an additional 93,121 shares during the quarter. Boston Common Asset Management LLC’s holdings in Colgate-Palmolive were worth $24,405,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of CL. Relyea Zuckerberg Hanson LLC grew its holdings in Colgate-Palmolive by 7.6% during the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 4,021 shares of the company’s stock valued at $366,000 after purchasing an additional 283 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its position in Colgate-Palmolive by 4.2% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 4,009 shares of the company’s stock valued at $364,000 after buying an additional 162 shares during the last quarter. Avanza Fonder AB acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $7,944,000. First Pacific Financial increased its position in shares of Colgate-Palmolive by 326.1% during the fourth quarter. First Pacific Financial now owns 1,960 shares of the company’s stock worth $178,000 after acquiring an additional 1,500 shares during the last quarter. Finally, Goldstone Financial Group LLC lifted its stake in shares of Colgate-Palmolive by 14.4% in the fourth quarter. Goldstone Financial Group LLC now owns 6,210 shares of the company’s stock worth $565,000 after acquiring an additional 781 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded up $0.16 during trading on Friday, hitting $88.72. 681,324 shares of the stock were exchanged, compared to its average volume of 4,618,708. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 12 month low of $79.69 and a 12 month high of $109.30. The stock’s fifty day moving average is $92.32 and its 200 day moving average is $97.85. The stock has a market cap of $72.48 billion, a PE ratio of 25.41, a P/E/G ratio of 3.01 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. Colgate-Palmolive’s payout ratio is currently 57.31%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on CL shares. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday. UBS Group decreased their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and an average target price of $102.11.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.